Pathstone Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$436K Sell
2024
Q3
$606K Buy
2024
Q2
$377K Buy
2024
Q1
$241K Buy